Biobank for studying blood disorders
Official title: Hematology Biobank: In Vitro Study of Blood Disorders
Run by Albert Einstein College of Medicine · NCT02442011 · Data updated 2026-11-12
This study is collecting blood samples and health information from people with blood disorders to help researchers learn more about these conditions and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Albert Einstein College of Medicine Academic / other |
| Locations | 1 site (The Bronx, New York) |
| Status | Recruiting |
| Started | January 2014 |
| Main results expected | January 2030 |
| Study ends | January 2030 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT02442011 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 18 years of age who have been diagnosed with any hematological disorder.
✕Probably not a fit
Patients who are under 18 years of age or unable to provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project establishes a biobank that collects blood specimens from individuals with various hematological disorders. It aims to compile patient histories and medical progress alongside de-identified blood samples, which will facilitate extensive analyses of red cells, plasma, serum, and DNA. The goal is to create a large database that enhances our understanding of blood disorders and contributes to future research and treatment advancements.
Why it matters
Potential benefit: If successful, this biobank could significantly improve our understanding of hematological disorders and lead to better diagnostic and treatment options for patients.
How similar studies have gone: Other biobanks focusing on hematological disorders have shown success in advancing research, making this approach both valuable and tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Above 12 years of age and referred to the Hematology Division at Montefiore-Einstein * Under the care of a Montefiore-Einstein hematologist for a hematologic disorder Exclusion Criteria: \- Do not meet the Inclusion Criteria listed above
Where it's running
-
Montefiore Medical Center
The Bronx, New York, United States Recruiting
Study contacts
- Principal investigator: Henny Billett — Albert Einstein College of Medicine
- Study coordinator: Swati Goel
- Email: swgoel@montefiore.org
- Phone: 7189204137
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Spatial navigation training using immersive VR in older adults with mild cognitive impairment
This trial tests whether older adults with mild cognitive impairment can complete a 24-session immersive VR navigation training and whether EEG together with VR can show brain activation changes during learning.
-
Morbidity and mortality after serratus anterior plane block for unilateral anterolateral rib fractures
This study tests whether giving a serratus anterior plane block (SAPB) within 24 hours to adults with multiple unilateral anterolateral rib fractures can reduce complications like pneumonia, shorten hospital stay, improve discharge outcomes, and lower death compared with usual opioid-based pain control.
-
Monitoring linezolid blood levels to reduce treatment interruptions in rifampin-resistant TB
This project will test whether checking linezolid blood levels and adjusting doses helps people with rifampin-resistant TB stay on treatment longer.
-
Impact of Reiki on recovery for women having breast surgery
This study is testing if a special relaxation technique called Medical Reiki can help women recovering from breast cancer surgery feel better and improve their quality of life.
-
Lactose-containing versus lactose-free milk for diabetes prevention in people with lactase non-persistence
This trial will test whether drinking lactose-containing milk instead of lactose-free milk for 12 weeks changes gut bacteria and improves blood sugar in people with lactase non-persistence and prediabetes.
-
Digital peer-support program using recovery stories for suicidal adolescents
The team will try a brief, low-cost digital program that shares short recovery stories to see if it reduces suicidal thoughts in ethnically diverse teens in The Bronx.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.